Anika Therapeutics Q3 2025 Earnings Preview

3 hours ago 1

Anika Therapeutics (ANIK) is scheduled to announce Q3 earnings results on Wednesday, November 5th, before market open.
The consensus EPS Estimate is $0.02 (+108.0% Y/Y) and the consensus Revenue Estimate is $27.8M (-28.4% Y/Y).
Over the last 2 years, ANIK has beaten EPS estimates 38% of the time and has beaten revenue estimates 88% of the time.